Physician profile

Michael J Oleary

Otology & Neurotology · San Diego, CA

NPI 1417986613

$2,160.96

in general payments reported to CMS, 2019-2025

4 companies · none reported in 2025

See the full distribution for Otology & Neurotology

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Travel and Lodging$436.83
Food and Beverage$331.42

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Stryker Corporation $1,388.42 2020-2023 Crossflow, Crossfire, Na
Medtronic, INC. $436.83 2023 Signia
Acera Surgical, INC. $220.98 2023-2024 Restrata Wound Matrix
Kerecis Limited $114.73 2022-2023 Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Michael J Oleary

$2,160.96

in general payments reported 2019-2025

Years
2020-2024
Top company
Stryker Corporation

https://glasscript.com/doctor/336225/michael-j-oleary

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.